|
MechanismOpioid receptors antagonists [+2] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date17 Apr 1995 |
加压素注射液治疗分布性休克低血压的有效性和安全性的多中心、随机、双盲、安慰剂对照的验证性临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled confirmatory clinical trial on the efficacy and safety of vasopressin injection in the treatment of hypotension in distributive shock
评价加压素注射液治疗分布性休克低血压的有效性和安全性
[Translation] To evaluate the efficacy and safety of vasopressin injection in the treatment of hypotension in distributive shock
100 Clinical Results associated with Chengdu Tiantaishan Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Chengdu Tiantaishan Pharmaceutical Co., Ltd.
100 Deals associated with Chengdu Tiantaishan Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Chengdu Tiantaishan Pharmaceutical Co., Ltd.